Federal Register / Vol. 75, No. 249 / Wednesday, December 29, 2010 / Notices 82035 

Submission of written/electronic statement 

for oral comments: January 11th by 5 p.m. 

ET. Submission of written comments: 

January 14th by 5 p.m. ET. 

Access: White Flint Metro (Red Line)— 

approximately 1⁄2 mile walk. On-site parking 

with parking validation available. 

Contact Person: Ms. Lina Perez, Office of 

Autism Research Coordination, National 

Institute of Mental Health, NIH, 6001 

Executive Boulevard, NSC, Room 8185a, 

Rockville, MD 20852, Phone: (301) 443–6040, 

E-mail: IACCPublicInquiries@mail.nih.gov. 

Please Note: 

Any member of the public interested in 

presenting oral comments to the Committee 

must notify the Contact Person listed on this 

notice by 5 p.m. ET on Monday, January 10, 

2011, with their request to present oral 

comments at the meeting. Interested 

individuals and representatives of 

organizations must submit a written/ 

electronic copy of the oral statement/ 

comments including a brief description of the 

organization represented by 5 p.m. ET on 

Tuesday, January 11, 2011. 

Statements submitted will become a part of 

the public record. Only one representative of 

an organization will be allowed to present 

oral comments, and presentations will be 

limited to three to five minutes per speaker, 

depending on number of speakers to be 

accommodated within the allotted time. 

Speakers will be assigned a time to speak in 

the order of the date and time when their 

request to speak is received, along with the 

required submission of the written/electronic 

statement by the specified deadline. 

In addition, any interested person may 

submit written comments to the IACC prior 

to the meeting by sending the comments to 

the Contact Person listed on this notice 

by 5 p.m. ET, Friday, January 14, 2011. The 

comments should include the name and, 

when applicable, the business or professional 

affiliation of the interested person. All 

written comments received by the deadlines 

for both oral and written public comments 

will be provided to the IACC for their 

consideration and will become part of the 

public record. The meeting will be open to 

the public through a conference call phone 

number and webcast live on the Internet. 

Members of the public who participate using 

the conference call phone number will be 

able to listen to the meeting but will not be 

heard. If you experience any technical 

problems with the conference call or 

webcast, please e-mail 

IACCTechSupport@acclaroresearch.com or 

call the IACC Technical Support Help Line 

at 443–680–0098. 

To access the webcast live on the Internet 

the following computer capabilities are 

required: (A) Internet Explorer 5.0 or later, 

Netscape Navigator 6.0 or later or Mozilla 

Firefox 1.0 or later; (B) Windows® 2000, XP 

Home, XP Pro, 2003 Server or Vista; (C) 

Stable 56k, cable modem, ISDN, DSL or 

better Internet connection; (D) Minimum of 

Pentium 400 with 256 MB of RAM 

(Recommended); ( E) Java Virtual Machine 

enabled (Recommended). 

Individuals who participate in person or by 

using these electronic services and who need 

special assistance, such as captioning of the 

conference call or other reasonable 

accommodations, should submit a request to 

the Contact Person listed on this notice at 

least 7 days prior to the meeting. 

As a part of security procedures, attendees 

should be prepared to present a photo ID at 

the meeting registration desk during the 

check-in process. Pre-registration is 

recommended. Seating will be limited to the 

room capacity and seats will be on a first 

come, first served basis, with expedited 

check-in for those who are pre-registered. 

Schedule is subject to change. 

Information about the IACC is available on 

the Web site: http://www.iacc.hhs.gov. 

Dated: December 21, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–32794 Filed 12–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Services Subcommittee of the 

Interagency Autism Coordinating 

Committee (IACC). 

The IACC Services Subcommittee will 

be holding a conference call on Friday, 

January 7, 2011. The subcommittee will 

discuss a set of draft recommendations 

to the Secretary of Health and Human 

Services on services and supports for 

people with Autism Spectrum Disorder. 

This conference call will be open to the 

public. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of meeting: Services Subcommittee. 

Date: January 7, 2011. 

Time: 10 a.m. to 12 p.m. Eastern Time. 

Agenda: The subcommittee will discuss a 

set of draft recommendations to the Secretary 

of Health and Human Services on services 

and supports for people with ASD. 

Place: No in-person meeting; conference 

call only. 

Conference Call Access: Dial: 888–456– 

0356. Access code: 1427016. 

Contact Person: Ms. Lina Perez, Office of 

Autism Research Coordination, National 

Institute of Mental Health, NIH, 6001 

Executive Boulevard, NSC, 8185a, Rockville, 

MD 20852. Phone: 301–443–6040. E-mail: 

IACCPublicInquiries@mail.nih.gov. 

Please Note: This conference call will be 

open to the public through a conference call 

in number and access code. Members of the 

public who participate using the conference 

call phone number will be able to listen to 

the discussion but will not be heard. If you 

experience any technical problems with the 

conference call, please e-mail 

IACCTechSupport@acclaroresearch.com or 

call the IACC Technical Support Help Line 

at 443–680–0098. 

Individuals who participate in person or by 

using these electronic services and who need 

special assistance, such as captioning of the 

conference call or other reasonable 

accommodations, should submit a request to 

the Contact Person listed on this notice at 

least 7 days prior to the meeting. 

This notice is being published less than 15 

days prior to the meeting due to the urgent 

need to discuss a set of recommendations to 

the Secretary of Health and Human Services 

on support and services so that these 

recommendations may be reviewed and 

approved by the full IACC committee at the 

meeting scheduled for January 18, 2011. 

Meeting schedule subject to change. 

Information about the IACC and a 

registration link for this meeting are available 

on the Web site: http://www.iacc.hhs.gov. 

Dated: December 21, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–32752 Filed 12–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Cancer Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board. Subcommittee on Clinical 

Investigations. 

Open: February 7, 2011, 6:30 p.m. to 8 p.m. 


srobinson on DSKHWCL6B1PROD with NOTICES
82036 Federal Register / Vol. 75, No. 249 / Wednesday, December 29, 2010 / Notices 

Agenda: Discussion on investigation of 

human cancers. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, Maryland 

20814. 

Contact Person: Dr. Jeff Abrams, Executive 

Secretary, National Cancer Institute, National 

Institutes of Health, 6130 Executive Blvd, 

Room 7018, Bethesda, MD 20892. (301) 496– 

6138. 

Name of Committee: National Cancer 

Advisory Board. 

Open: February 8, 2011, 9 a.m. to 3:30 p.m. 

Agenda: Program reports and 

presentations; business of the Board. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327. (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Closed: February 8, 2011, 3:45 p.m. to 5 

p.m. 

Agenda: Review of grant applications. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327. (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Open: February 9, 2011, 9 a.m. to 12 p.m. 

Agenda: Program reports and 

presentations; business of the Board. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327. (301) 496–5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport 

shuttles, will be inspected before being 

allowed on campus. Visitors will be asked to 

show one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the purpose 

of their visit. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 22, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–32750 Filed 12–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental and 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review of EUREKA R01s. 

Date: February 23, 2011. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Jonathan Horsford, PhD, 

Scientific Review Officer, Natl. Inst. of Dental 

and Craniofacial Research, National Institutes 

of Health, 6701 Democracy Blvd., Room 664, 

Bethesda, MD 20892, 301–594–4859, 

horsforj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: December 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–32748 Filed 12–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: 2011 Opioid Treatment 

Program (OTP) Supplement Survey— 

NEW 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) Center for Behavioral Health 

Statistics and Quality (CBHSQ) 

(formerly the Office of Applied 

Studies—OAS), in conjunction with the 

Center for Substance Abuse Treatment 

(CSAT), will conduct a facility-level 

census survey of opioid treatment 

programs (OTPs). Approximately 1,200 

substance abuse treatment facilities 

identified by SAMHSA as being 

certified OTPs will make up the survey 

universe. In order to realize efficiencies 

in cost and data analysis, the survey 

will be conducted in conjunction with 

the 2011 National Survey of Substance 

Abuse Treatment Facilities (N–SSATS, 

OMB No. 0930–0106). However, a 

separate OMB approval will be 

requested for the OTP survey. 

The OTP survey will use the same 

point prevalence date as the N–SSATS 

and will offer the same response options 

(paper questionnaire, online via the 

Internet, or by telephone with an 

interviewer). The information collected 

will include detailed information on 

OTP client characteristics and OTP 

facility operations, information that is 

not currently obtained by the N–SSATS 

or other federally-sponsored surveys. 

The findings will supplement 

information collected by the annual 

N–SSATS and will be published by 

SAMHSA in a separate report on Opioid 

Treatment Programs. Survey data will 

also be used to update SAMHSA’s 

‘‘Medication-Assisted Treatment for 

Opioid Addiction State Profiles.’’ These 

publications will be used by the Federal 

government, State and local 

governments, the U.S. Congress, 

researchers, and other health care 

professionals. The following Table 


srobinson on DSKHWCL6B1PROD with NOTICES